These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

853 related items for PubMed ID: 30059372

  • 1. Stevens-Johnson Syndrome: A Challenging Diagnosis.
    Davis WD, Schafer PA.
    Adv Emerg Nurs J; 2018; 40(3):176-182. PubMed ID: 30059372
    [Abstract] [Full Text] [Related]

  • 2. Human immunodeficiency virus, pregnancy, and Stevens-Johnson syndrome.
    Shilad A, Predanic M, Perni SC, Houlihan C, Principe D.
    Obstet Gynecol; 2005 May; 105(5 Pt 2):1254-6. PubMed ID: 15863600
    [Abstract] [Full Text] [Related]

  • 3. Burn Center Care of Patients with Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis.
    Cartotto R.
    Clin Plast Surg; 2017 Jul; 44(3):583-595. PubMed ID: 28576247
    [Abstract] [Full Text] [Related]

  • 4. Acute blistering diseases on the burn ward: Beyond Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis.
    Richer V, Bouffard D, Bélisle A, Duranceau L, Perreault I, Provost N.
    Burns; 2013 Sep; 39(6):1290-6. PubMed ID: 23597847
    [Abstract] [Full Text] [Related]

  • 5. Stevens Johnson syndrome-Toxic Epidermal Necrolysis Overlap induced by sulfasalazine treatment: a case report.
    Zizi N, Elmrahi A, Dikhaye S, Fihmi N, Alami Z.
    Tunis Med; 2015 Jul; 93(7):413-5. PubMed ID: 26757493
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Effectiveness, safety and tolerability of cyclosporine versus supportive treatment in Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis: A record-based study.
    Mohanty S, Das A, Ghosh A, Sil A, Gharami RC, Bandyopadhyay D, Das NK.
    Indian J Dermatol Venereol Leprol; 2017 Jul; 83(3):312-316. PubMed ID: 28366923
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Cutaneous adverse reactions to valdecoxib distinct from Stevens-Johnson syndrome and toxic epidermal necrolysis.
    Ziemer M, Wiesend CL, Vetter R, Weiss J, Blaschke S, Norgauer J, Mockenhaupt M.
    Arch Dermatol; 2007 Jun; 143(6):711-6. PubMed ID: 17576936
    [Abstract] [Full Text] [Related]

  • 11. Stevens-Johnson syndrome after erythromycin therapy while deployed at sea.
    Williams DA.
    Mil Med; 2000 Aug; 165(8):636-7. PubMed ID: 10957862
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Possible lenalidomide-induced Stevens-Johnson syndrome during treatment for multiple myeloma.
    Boruah PK, Bolesta S, Shetty SM.
    Pharmacotherapy; 2011 Sep; 31(9):925. PubMed ID: 21923596
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Stevens-Johnson syndrome and toxic epidermal necrolysis: a report of six cases.
    Kara A, Devrim İ, Çağlar İ, Bayram N, Kundak S, Apa H, Altan EV.
    Turk J Pediatr; 2019 Sep; 61(4):538-543. PubMed ID: 31990471
    [Abstract] [Full Text] [Related]

  • 16. Toxic Epidermal Necrolysis: A Dermatologic Emergency and the Role of the Oral and Maxillofacial Surgeon.
    Wolf B, Sadoff R, Nannini V.
    J Oral Maxillofac Surg; 2018 Aug; 76(8):1688-1694. PubMed ID: 29555183
    [Abstract] [Full Text] [Related]

  • 17. A Review of the Management of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis.
    Woolum JA, Bailey AM, Baum RA, Metts EL.
    Adv Emerg Nurs J; 2019 Aug; 41(1):56-64. PubMed ID: 30702535
    [Abstract] [Full Text] [Related]

  • 18. Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis in the Pediatric Population: A Review.
    Alerhand S, Cassella C, Koyfman A.
    Pediatr Emerg Care; 2016 Jul; 32(7):472-6. PubMed ID: 27380605
    [Abstract] [Full Text] [Related]

  • 19. Chemotherapy patient with Stevens-Johnson Syndrome presents to the Emergency Department: A case report.
    Widmer S, Grossman M.
    Am J Emerg Med; 2018 Jul; 36(7):1325.e3-1325.e4. PubMed ID: 29743141
    [Abstract] [Full Text] [Related]

  • 20. Severe cutaneous adverse reactions: acute generalized exanthematous pustulosis, toxic epidermal necrolysis and Stevens-Johnson syndrome.
    Harr T, French LE.
    Med Clin North Am; 2010 Jul; 94(4):727-42, x. PubMed ID: 20609860
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 43.